Skip to content

Study · Not a test of the peptide alone · 2022

4 results

A novel pharmacological treatment concept for neuroprotection in severe traumatic brain injury-Two case reports.

Trimmel H, Herzer G, Derdak C, Kettenbach J, Grgac I

Clinical case reports20 Nov 2022Cited by 4 (Europe PMC)

PMID36419580 (opens in a new tab)PMCIDPMC9676123 (opens in a new tab)DOI10.1002/ccr3.6626 (opens in a new tab)PepBankPUB-36419580
Read at sourcePubMedAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study4

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone4

In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cerebrolysin.

  1. 01HumanNot a test of Cerebrolysin aloneCase report or seriesEfficacy outcome

    In two severe traumatic brain injury cases, Cerebrolysin with Citicoline was followed by Glasgow Outcome Scores of 6 and 5.

    In plain wordsIn two patients with severe brain injury, Cerebrolysin with Citicoline was followed by Glasgow Outcome Scores of 6 and 5.

    Peptide
    Cerebrolysin
    Outcome
    Not applicableGlasgow Outcome Score
    Study

    n = 2

    Outcome group
    Neuroprotection · Nervous system and cognition

    Measurements

    Glasgow Outcome Score
    6
    first patient
    Glasgow Outcome Score
    5
    second patient

    Source sentences

    Summary
    They achieved a Glasgow Outcome Score of 6 and 5 and grades 2 and 4 on the modified Rankin Scale, respectively.
    1 context sentence
    Summary · context
    Here, we present a combined treatment with Cerebrolysin and Citicoline in two cases.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  2. 02HumanNot a test of Cerebrolysin aloneCase report or seriesEfficacy outcome

    In two severe traumatic brain injury cases, Cerebrolysin with Citicoline was followed by modified Rankin Scale grades 2 and 4.

    In plain wordsIn two patients with severe brain injury, Cerebrolysin with Citicoline was followed by modified Rankin Scale grades 2 and 4.

    Peptide
    Cerebrolysin
    Outcome
    Not applicableModified Rankin Scale
    Study

    n = 2

    Outcome group
    Neuroprotection · Nervous system and cognition

    Measurements

    Modified Rankin Scale
    2
    first patient
    Modified Rankin Scale
    4
    second patient

    Source sentences

    Summary
    They achieved a Glasgow Outcome Score of 6 and 5 and grades 2 and 4 on the modified Rankin Scale, respectively.
    1 context sentence
    Summary · context
    Here, we present a combined treatment with Cerebrolysin and Citicoline in two cases.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  3. 03HumanNot a test of Cerebrolysin aloneCase report or seriesEfficacy outcome

    After Cerebrolysin with Citicoline, both severe traumatic brain injury patients could largely perform self-care in daily activities.

    In plain wordsBoth patients could largely care for themselves after Cerebrolysin with Citicoline.

    Peptide
    Cerebrolysin
    Outcome
    Not applicableActivities of daily life
    Study

    n = 2

    Outcome group
    Exercise and physical function · Nervous system and cognition

    Source sentences

    Summary
    Currently, both are able to take care of themselves in activities of daily life to a large extent.
    1 context sentence
    Summary · context
    Here, we present a combined treatment with Cerebrolysin and Citicoline in two cases.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

  4. 04HumanNot a test of Cerebrolysin aloneCase report or seriesSafety outcome

    In two severe traumatic brain injury cases, the authors reported recovery with Cerebrolysin and Citicoline without relevant side effects.

    In plain wordsIn two patients with severe brain injury, the authors reported no relevant side effects with Cerebrolysin and Citicoline.

    Peptide
    Cerebrolysin
    Outcome
    Not applicableRelevant side effects
    Study

    n = 2

    Outcome group
    Adverse events · Whole body

    Source sentences

    Summary
    Our clinical experience and data suggest that the combined administration of Citicoline and Cerebrolysin may contribute to better recovery, without relevant side effects.
    1 context sentence
    Summary · context
    Here, we present a combined treatment with Cerebrolysin and Citicoline in two cases.

    In this study, Cerebrolysin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cerebrolysin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.